Overview
Drug Interaction Study of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects
Status:
Completed
Completed
Trial end date:
2018-01-30
2018-01-30
Target enrollment:
0
0
Participant gender:
Male
Male
Summary
The purpose of this study is to evaluate the Drug interaction and safety of Fimasartan/Amlodipine and Hydrochlorothiazide in Healthy Male volunteers.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Boryung Pharmaceutical Co., LtdTreatments:
Amlodipine
Hydrochlorothiazide
Criteria
Inclusion Criteria:- A healthy Male adults aged 19-50 years
Exclusion Criteria:
- History or presence of clinically significant medical or psychiatric condition or
disease.
- Hypersensitivity to ingredient of IP and other medication, food.
- Participation in any other study within 3months.
- History of whole blood donation within 2months and Apheresis 1month.